TTRX
Financials
- Market Capitalization 292.82 M
- Employee 2
- Founded 2015
- CEO N/A
- Website www.turntherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG002QTLH75
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3299 |  IRD Opus Genetics, Inc. - Common Stock | 3.70 USD | -3.90% | -8.64% | +7.25% | -0.54% | 307.82 M USD | ||
| 3301 |  OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 5.18 USD | +1.37% | -3.36% | +34.55% | +90.44% | 311.34 M USD | ||
| 3350 |  FATE Fate Therapeutics, Inc. - Common Stock | 2.42 USD | -4.72% | +3.86% | +3.86% | +124.07% | 289.97 M USD | ||
| 3351 |  FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.86 USD | +0.26% | +0.78% | +4.61% | -42.47% | 294.51 M USD |
Frequently asked questions about Turn Therapeutics Inc. Common Stock
What is the Turn Therapeutics Inc. Common Stock stock price today?
The current price of Turn Therapeutics Inc. Common Stock (TTRX) is 9.83. Over the past 24 hours, the stock has changed by -2.77%. Follow the TTRX chart for real-time price dynamics.
What is the stock ticker of Turn Therapeutics Inc. Common Stock?
Turn Therapeutics Inc. Common Stock trades under the ticker TTRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Turn Therapeutics Inc. Common Stock stock going up?
TTRX has changed by +3.91% over the last week, +28.50% over the last month, and -1.70% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Turn Therapeutics Inc. Common Stock?
Turn Therapeutics Inc. Common Stock currently has a market capitalization of 292.82 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Turn Therapeutics Inc. Common Stock earnings last quarter?
Last quarter, Turn Therapeutics Inc. Common Stock reported earnings of -0.2 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Turn Therapeutics Inc. Common Stock revenue for the last quarter?
Turn Therapeutics Inc. Common Stock reported quarterly revenue of -3.98 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Turn Therapeutics Inc. Common Stock net income for the last quarter?
Turn Therapeutics Inc. Common Stock reported net income of -5.85 M for the last quarter. The previous quarter showed -970.97 K, which means net income changed by -502.46%.
How many employees does Turn Therapeutics Inc. Common Stock have?
As of the latest available data, Turn Therapeutics Inc. Common Stock has 2 employees. Workforce size can provide additional context about the company's scale and operations.
What is Turn Therapeutics Inc. Common Stock EBITDA?
Turn Therapeutics Inc. Common Stock EBITDA is -5.59 M, and its EBITDA margin is 140.54%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Turn Therapeutics Inc. Common Stock stock?
You can buy Turn Therapeutics Inc. Common Stock (TTRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Turn Therapeutics Inc. Common Stock stock?
Investing in Turn Therapeutics Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TTRX chart and related analysis on metatrader.com as part of your research.